Remon J, Besse B, Aix SP, Callejo A, et al. Osimertinib treatment based on plasma T790M monitoring in patients with EGFR-mutant non-small cell lung cancer (NSCLC): EORTC Lung Cancer Group 1613 APPLE phase II randomized clinical trial. Ann Oncol 2023 Feb 28:S0923-7534(23)00089-3. doi: 10.1016/j.annonc.2023.
PMID: 36863484